GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (XPAR:TNG) » Definitions » Price-to-Tangible-Book

Transgene (XPAR:TNG) Price-to-Tangible-Book : 8.68 (As of May. 16, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Transgene Price-to-Tangible-Book?

As of today (2024-05-16), Transgene's share price is €1.336. Transgene's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €0.15. Hence, Transgene's Price to Tangible Book Ratio of today is 8.68.

The historical rank and industry rank for Transgene's Price-to-Tangible-Book or its related term are showing as below:

XPAR:TNG' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.97   Med: 3.78   Max: 8.99
Current: 8.91

During the past 13 years, Transgene's highest Price to Tangible Book Ratio was 8.99. The lowest was 1.97. And the median was 3.78.

XPAR:TNG's Price-to-Tangible-Book is ranked worse than
85.53% of 1230 companies
in the Biotechnology industry
Industry Median: 2.8 vs XPAR:TNG: 8.91

A closely related ratio is called PB Ratio. As of today, Transgene's share price is €1.336. Transgene's Book Value per Sharefor the quarter that ended in Dec. 2023 was €0.16. Hence, Transgene's P/B Ratio of today is 8.62.


Transgene Price-to-Tangible-Book Historical Data

The historical data trend for Transgene's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Price-to-Tangible-Book Chart

Transgene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 2.73 3.70 4.40 8.90

Transgene Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.70 4.14 4.40 8.47 8.90

Competitive Comparison of Transgene's Price-to-Tangible-Book

For the Biotechnology subindustry, Transgene's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgene's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgene's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Transgene's Price-to-Tangible-Book falls into.



Transgene Price-to-Tangible-Book Calculation

Transgene's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=1.336/0.154
=8.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Transgene Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Transgene's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgene (XPAR:TNG) Business Description

Traded in Other Exchanges
Address
400 Boulevard Gonthier d’Andernach, Parc d’Innovation - CS80166, Illkirch-Graffenstaden, FRA, 67400
Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products.

Transgene (XPAR:TNG) Headlines

No Headlines